Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies

Background and study aims: Sphincter of Oddi manometry (SOM), performed at endoscopic retrograde cholangiopancreatography (ERCP), is the gold standard for diagnosing sphincter of Oddi dysfunction (SOD). The question remains as to whether the short-term manometric recordings reflect the 24-hour pathophysiology of the sphincter. The aim of this study was to determine the frequency of SOD in persistently symptomatic patients with previously normal SOM studies.

Patients and methods: All patients who underwent ERCP for suspected SOD over a 13-year period (1994 – 2007) were considered for inclusion in the study. Patients with an intact papilla and a previously normal SOM who had a repeat ERCP for persistent symptoms formed the study group. SOM was performed in conventional retrograde fashion.

Results: In all, 5352 patients without prior papillary intervention underwent SOM during the study period. A total of 1037 patients had normal SOM, and of these, 30 patients (27 female, mean age 40.1 years) underwent repeat ERCP for persistent symptoms. The median duration between the two ERCPs was 493.5 days (range 52 – 3538 days). In these 30 patients, SOD classification prior to the initial ERCP was: type I in one patient (not treated in 1994), type II in 17 patients, and type III in 12 patients. Of the 30 patients, 12 (40 %) had normal SOM at repeat ERCP; SOD was diagnosed in 18/30 (60 %) patients.

Conclusions: A single SOM study may not represent the day-to-day physiology of the sphincter of Oddi; sphincter pathology may progress over time. One normal exam may not rule out SOD. A repeat ERCP with manometry may be warranted in a subset of patients with persistent debilitating symptoms and a high index of suspicion for SOD. Outcome data are needed to determine whether this approach justifies the potential risks of ERCP.

References

• 1 Lehman G A. Endoscopic sphincter of Oddi manometry: a clinical practice and research tool.  Gastrointest Endosc. 1991;  37 490-492
• 2 Park S H, Watkins J L, Fogel E L. et al . Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.  Gastrointest Endosc. 2003;  57 483-491
• 3 Anderson T M, Pitt H A, Longmire W P jr. Experience with sphincteroplasty and sphincterotomy in pancreatobiliary surgery.  Ann Surg. 1985;  201 399-406
• 4 Varadarajulu S, Hawes R H, Cotton P B. Determination of sphincter of Oddi dysfunction in patients with prior normal manometry.  Gastrointest Endosc. 2003;  58 341-344
• 5 Thune A, Scicchitano J, Roberts-Thomson I. et al . Reproducibility of endoscopic sphincter of Oddi manometry.  Dig Dis Sci. 1991;  36 1401-1405
• 6 Guelrud M, Mendoza S, Rossiter G. et al . Sphincter of Oddi manometry in healthy volunteers.  Dig Dis Sci. 1990;  35 38-46
• 7 Geenen J E, Hogan W J, Dodds W J. et al . The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with suspected sphincter of Oddi dysfunction.  N Engl J Med. 1989;  320 82-87
• 8 Smithline A, Hawes R, Lehman G. Sphincter of Oddi manometry: interobserver variability.  Gastrointest Endosc. 1993;  39 486-491
• 9 Sherman S, Gottlieb K, Uzer M F. et al . Effects of meperidine on the pancreatic and biliary sphincter.  Gastrointest Endosc. 1996;  44 239-242
• 10 Elta G H, Barnett J L. Meperidine need not be proscribed during sphincter of Oddi manometry.  Gastrointest Endosc. 1994;  40 7-9
• 11 Fogel E L, Sherman S, Bucksot L. et al . Effects of droperidol on the pancreatic and biliary sphincters.  Gastrointest Endosc. 2003;  58 488-492
• 12 Eversman D, Fogel E L, Rusche M. et al . Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction.  Gastrointest Endosc. 1999;  50 637-641
• 13 Guelrud M, Rossiter A, Souney P F. et al . The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia.  Am J Gastroenterol. 1991;  86 581-585
• 14 Lee S K, Kim M H, Kim H J. et al . Electroacupuncture may relax the sphincter of Oddi in humans.  Gastrointest Endosc. 2001;  53 211-216
• 15 Torsoli A, Corazziari E, Habib F I. et al . Frequencies and cyclical pattern of the human sphincter of Oddi phasic activity.  Gut. 1986;  27 363-369
• 16 Blaut U, Alazmi W, Sherman S. et al . The influence of variable stiffness guidewires on basal biliary sphincter pressure measured at ERCP.  Endoscopy. , [in press]
• 17 Drossman D A, Li Z, Andruzzi E. et al . U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.  Dig Dis Sci. 1993;  38 1569-1580
• 18 Freeman M L, Guda N M. Prevention of post-ERCP pancreatitis: a comprehensive review.  Gastrointest Endosc. 2004;  59 845-864
• 19 Freeman M L, Nelson D B, Sherman S. et al . Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
• 20 Singh P, Das A, Isenberg G. et al . Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.  Gastrointest Endosc. 2004;  60 544-550
• 21 Das A, Singh P, Sivak M V jr. et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.  Gastrointest Endosc. 2007;  65 960-968
• 22 Saad A M, Fogel E L, McHenry L. et al . Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.  Gastrointest Endosc. 2008;  67 255-261
• 23 Arguedas M R, Linder J D, Wilcox C M. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy.  Endoscopy. 2004;  36 174-178
• 24 Lawrence C, Howell D A, Conklin D E. et al . ERCP sphincterotomy without initial manometry for type II sphincter of Oddi dysfunction patients: a safe and effective strategy (abstract).  Gastrointest Endosc. 2004;  59 P99